Literature DB >> 20478580

The Swedish reflux trial in children: I. Study design and study population characteristics.

Per Brandström1, Elisabeth Esbjörner, Maria Herthelius, Gundela Holmdahl, Göran Läckgren, Tryggve Nevéus, Ulla Sillén, Rune Sixt, Ingrid Sjöberg, Eira Stokland, Ulf Jodal, Sverker Hansson.   

Abstract

PURPOSE: We compared the rates of febrile urinary tract infection, kidney damage and reflux resolution in children with vesicoureteral reflux treated in 3 ways, including antibiotic prophylaxis, endoscopic therapy and surveillance with antibiotics only for symptomatic urinary tract infection.
MATERIALS AND METHODS: Children 1 to younger than 2 years with grade III-IV reflux were recruited into this prospective, open, randomized, controlled, multicenter study and followed for 2 years after randomization. The main study end points were recurrent febrile urinary tract infection, renal status on dimercapto-succinic acid scintigraphy and reflux status. Outcomes were analyzed by the intent to treat principle.
RESULTS: During a 6-year period 128 girls and 75 boys entered the study. In 96% of cases reflux was detected after urinary tract infection. The randomization procedure was successful and resulted in 3 groups matched for relevant factors. Recruitment was slower than anticipated but after patients were entered adherence to the protocol was good. Of the children 93% were followed for the intended 2 years without a treatment arm change. All except 2 patients completed 2-year followup scintigraphy.
CONCLUSIONS: Recruitment was difficult but a substantial number of children were entered and randomly assigned to 3 groups with similar basic characteristics. Good adherence to the protocol made it possible to address the central study questions. Copyright (c) 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20478580     DOI: 10.1016/j.juro.2010.01.055

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  [Treatment of vesicoureteral reflux in childhood].

Authors:  I Körner; J Steffens
Journal:  Urologe A       Date:  2010-10       Impact factor: 0.639

Review 2.  Vesicoureteral reflux--the role of bladder and bowel dysfunction.

Authors:  Jack S Elder; Mireya Diaz
Journal:  Nat Rev Urol       Date:  2013-10-15       Impact factor: 14.432

Review 3.  [Current and practice-relevant news from pediatric urology].

Authors:  R Stein; A Schröder; M Goepel
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

Review 4.  [Vesicoureteral reflux: diagnostics and therapy].

Authors:  W H Rösch; V Geyer
Journal:  Urologe A       Date:  2011-06       Impact factor: 0.639

Review 5.  Antibiotic prophylaxis in pediatric urology: an update.

Authors:  Saul P Greenfield
Journal:  Curr Urol Rep       Date:  2011-04       Impact factor: 3.092

Review 6.  Vesicoureteral reflux and reflux nephropathy.

Authors:  Tej K Mattoo
Journal:  Adv Chronic Kidney Dis       Date:  2011-09       Impact factor: 3.620

7.  Different imaging strategies in febrile urinary tract infection in childhood. What, when, why?

Authors:  Diego De Palma; Gianantonio Manzoni
Journal:  Pediatr Radiol       Date:  2013-03-24

Review 8.  Childhood vesicoureteral reflux studies: registries and repositories sources and nosology.

Authors:  Russell W Chesney; Andrea B Patters
Journal:  J Pediatr Urol       Date:  2012-10-05       Impact factor: 1.830

Review 9.  Efficacy of antibiotic prophylaxis in children with vesicoureteral reflux: systematic review and meta-analysis.

Authors:  Hsin-Hsiao S Wang; Rasheed A Gbadegesin; John W Foreman; Shashi K Nagaraj; Delbert R Wigfall; John S Wiener; Jonathan C Routh
Journal:  J Urol       Date:  2014-09-06       Impact factor: 7.450

10.  Individualizing management of vesicoureteral reflux.

Authors:  Christopher S Cooper
Journal:  Nephrourol Mon       Date:  2012-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.